Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. D. Iantchina, T. V. Ivthcik, N. E. Hodgaynce, A. N. Kokosov, N. V. Kuzmenkova, L. N. Karlova, E. A. Kiseleva, V. V. Lim (Saint-Petersburg, Russia). Specific features of phenotypes of polymorphic haptoglobin system in patients with chronic bronchitis and healthy smokers. Eur Respir J 2001; 16: Suppl. 31, 276

Member's Comments

No comment yet.

Related content which might interest you: A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients Source: Eur Respir J 2007; 30: Suppl. 51, 177s Year: 2007 Can breathing pattern parameters be differentiated between healthy and severe asthma patients? Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012 Characterisation of a cohort of asthmatics with severe concordant eosinophilic disease according to their IgE status Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Some local markers indices of saliva inflammation in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002 Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: 472-478 Year: 2006 Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Lymphocyte subpopulations in serum in patients with nonallergic asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 288s Year: 2006 Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 The genetic markers (HLA system) of steroid-resistance in severe bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006 Differences in migrating neutrophils from patients with COPD compared with healthy smokers and non smokers and patients with alpha 1 antitrypsin deficiency Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019